Invention Grant
- Patent Title: NK1 receptor antagonist composition
- Patent Title (中): NK1受体拮抗剂组合物
-
Application No.: US12445811Application Date: 2007-10-12
-
Publication No.: US08426386B2Publication Date: 2013-04-23
- Inventor: Takuya Uozumi , Satoru Morishita , Yoshimasa Tanaka , Mayumi Yumoto
- Applicant: Takuya Uozumi , Satoru Morishita , Yoshimasa Tanaka , Mayumi Yumoto
- Applicant Address: JP Tokyo
- Assignee: Lion Corporation
- Current Assignee: Lion Corporation
- Current Assignee Address: JP Tokyo
- Agency: Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P.
- Priority: JP2006-281907 20061016
- International Application: PCT/JP2007/069959 WO 20071012
- International Announcement: WO2008/047709 WO 20080424
- Main IPC: A01N43/04
- IPC: A01N43/04 ; A61K31/715
Abstract:
An NK1 receptor antagonist composition of the present invention uses maltooligosaccharide having an NK1 receptor antagonistic activity as an active ingredient. A suitable amount of the maltooligosaccharide to be blended in the NK1 receptor antagonist composition of the present invention is 0.000001 to 70% by weight. The NK1 receptor antagonist composition of the present invention is prepared for use into various forms of external agents, internal medicines, foods and beverages by blending various materials as the ingredients other than the active ingredient. The NK1 receptor antagonist composition of the present invention has high safety for being used for pharmaceuticals and has satisfactory therapeutic effects.
Public/Granted literature
- US20110039801A1 NK1 RECEPTOR ANTAGONIST COMPOSITION Public/Granted day:2011-02-17
Information query
IPC分类:
